Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-27T15:01:44.987Z Has data issue: false hasContentIssue false

Signals generating anorexia during acute illness

Symposium on ‘Eating, illness and the gut: is there disorder in the house?’

Published online by Cambridge University Press:  16 July 2007

Wolfgang Langhans*
Affiliation:
Physiology and Behaviour Group, Institute of Animal Sciences, ETH Zurich, Schwerzenbach, Switzerland
*
Corresponding author: Dr Wolfgang Langhans, fax +41 44 655 7206, email wolfgang-langhans@ethz.ch
Rights & Permissions [Opens in a new window]

Abstract

Anorexia is part of the body's acute-phase response to illness. Microbial products such as lipopolysaccharides (LPS), which are also commonly used to model acute illness, trigger the acute-phase response and cause anorexia mainly through pro-inflammatory cytokines. LPS stimulate cytokine production through the cell-surface structural molecule CD14 and toll-like receptor-4. Cytokines ultimately change neural activity in brain areas controlling food intake and energy balance. The blood–brain barrier endothelial cells (BBB EC) are an important site of cytokine action in this context. BBB EC and perivascular cells (microglia and macrophages) form a complex regulatory interface that modulates neuronal activity by the release of messengers (e.g. PG, NO) in response to peripheral challenges. Serotonergic neurons originating in the raphe nuclei and glucagon-like peptide-1-expressing neurons in the hindbrain may be among the targets of these messengers, because serotonin (5-HT), acting through the 5-HT2C receptor, and glucagon-like peptide-1 have recently emerged as neurochemical mediators of LPS anorexia. The central melanocortin system, which is a downstream target of serotonergic neurons, also appears to be involved in mediation of LPS anorexia. Interestingly, LPS also reduce orexin expression and the activity of orexin neurons in the lateral hypothalamic area of fasted mice. As the eating-stimulatory properties of orexin are apparently related to arousal, the inhibitory effect of LPS on orexin neurons might be involved in LPS-induced inactivity and anorexia. In summary, the immune signalling pathways of LPS-induced, and presumably acute illness-induced, anorexia converge on central neural signalling systems that control food intake and energy balance in healthy individuals.

Type
Research Article
Copyright
Copyright © The Author 2007

Abbreviations:
BBB

blood–brain barrier

EC

endothelial cells

CNTF

ciliary neurotrophic factor

5-HT

serotonin

IFN-γ

interferon-γ

LPS

lipopolysaccharides

MCn-R

melanocortin receptors, where n is 3 or 4

TLR

toll-like receptor

Acute infections and other immune challenges trigger a generalized host defence reaction (acute-phase response) that comprises several physiological and behavioural changes including anorexia (for example, see Hart, Reference Hart1988). The anorexia occurs largely independently of other acute-phase response phenomena such as fever, lethargy or metabolic changes (for review, see Langhans, Reference Langhans2000) and appears to be beneficial for the host initially (for example, see Murray   Murray, Reference Murray and Murray1979), but becomes deleterious over time. The present article reviews the signals that cause anorexia during acute illness. Most of the pertinent knowledge is derived from studies using lipopolysaccharides (LPS), the Gram-negative bacterial cell-wall constituents that are extensively used to model microbial infections.

The model of lipopolysaccharide-induced anorexia

General features

LPS are powerful stimuli of innate immune responses because they have no structural homologue in mammalian organisms (Beutler, Reference Beutler2000). They are released during bacteriolysis or during periods of rapid bacterial proliferation (Rietschel et al. Reference Rietschel, Schletter, Weidemann, El Samalouti, Mattern and Zahringer1998). LPS administration triggers a profound pro-inflammatory cytokine response (Abram et al. Reference Abram, Vu, Wraber and Doric2000) and, hence, mimics many features of the acute-phase response including the anorexia. LPS have been shown to induce taste aversions in different experimental situations (Langhans et al. Reference Langhans, Balkowski and Savoldelli1991; Weingarten et al. Reference Weingarten, Senn and Langhans1993), and conditioning may contribute to LPS anorexia under conditions that favour associative learning (Weingarten et al. Reference Weingarten, Senn and Langhans1993; Exton et al. Reference Exton, Bull and King1995). However, such learned effects do not appear to play a major role in the anorectic response to LPS under normal circumstances, i.e. when the illness is not associated with a novel diet (Weingarten et al. Reference Weingarten, Senn and Langhans1993). Fasting attenuates the feeding-inhibitory effect of LPS (Gautron et al. Reference Gautron, Mingam, Moranis, Combe and Laye2005), which may be related to the presumed lowering of the body-weight set point by inflammatory mechanisms (Lennie, Reference Lennie1998). While the exact mechanism(s) of this phenomenon are unknown, energy restriction apparently attenuates the stimulatory effect of LPS on macrophage cytokine production (Vega et al. Reference Vega, de Cabo and De Maio2004) and hypothalamic paraventricular nucleus activation (as evidenced by a reduction in LPS-induced c-fos expression; Gautron et al. Reference Gautron, Mingam, Moranis, Combe and Laye2005), both of which might curb anorexia in response to LPS. It is also interesting that LPS induces a stronger inhibition of feeding in females than in males (Geary et al. Reference Geary, Asarian, Sheahan and Langhans2004), a gender difference mainly related to oestrogen (Geary, Reference Geary2001; Geary et al. Reference Geary, Asarian, Sheahan and Langhans2004). While it is generally accepted that LPS induce anorexia by stimulating the production of cytokines that then act on the brain to inhibit feeding, there are several open questions, including: (1) where and in which cells the stimulation of cytokine production occurs; (2) which brain areas and neurochemicals mediate the resulting behavioural response.

Lipopolysaccharide receptor mechanisms

LPS trigger biological responses by LPS-binding protein-mediated binding to the cell-surface glycoprotein CD14 (Schutt et al. Reference Schutt, Bernheiden, Grunwald, Stelter, Menzel, Muller, Fan and Jack1999), which is present on many immune cells as well as on endothelial cells (EC). Furthermore, in cells devoid of CD14 the circulating soluble form of CD14 can replace membrane-bound CD14 (Akira, Reference Akira2000). LPS, CD14, the myeloid differentiation protein 2 and the toll-like receptor (TLR)-4, which is the ‘true’ LPS receptor (Akira, Reference Akira2000; Beutler, Reference Beutler2000), form the LPS receptor complex. TLR are a family of transmembrane proteins that mainly act as receptors for microbial substances (Akira, Reference Akira2000; Beutler, Reference Beutler2000). It has been shown that CD14 and TLR4, but not TLR2, are essential for the full expression of LPS anorexia (von Meyenburg et al. Reference von Meyenburg, Hrupka, Arsenijevic, Schwartz, Landmann and Langhans2004). LPS activation of TLR4 leads to recruitment of the myeloid adapter protein MyD88, which forms a complex with the Ser/Thr kinase IL-1 receptor-associated kinase that interacts with TNF receptor-activated factor 6. This process activates the transcription factors NF-κB and activating protein-1 (Beutler, Reference Beutler2002) and ultimately triggers the production of pro-inflammatory cytokines, prostanoids and other downstream mediators of LPS effects. The intracellular pathways of LPS and cytokine signalling overlap and have been extensively investigated. The absence of MyD88 signalling has recently been shown to completely eliminate anorexia in response to either LPS or IL-1β (Ogimoto et al. Reference Ogimoto, Harris and Wisse2006). Interference with NF-κB production has also been shown to block the feeding-inhibitory effect of IL-1β (Nadjar et al. Reference Nadjar, Bluthe, May, Dantzer and Parnet2005) and is the most likely mechanism by which genetic lack of PPARβ, administration of phosphodiesterase inhibitors such as pentoxifylline (Porter et al. Reference Porter, Hrupka, Altreuther, Arnold and Langhans2000) and some other pharmacological interventions antagonize the feeding-inhibitory effect of LPS (for review, see Langhans, Reference Langhans, Stricker and Woods2004). The neural mechanism(s) that mediate these effects, however, have not yet been determined. In summary, various experimental manipulations that interfere with TLR4 signalling and, hence, pro-inflammatory cytokine production, antagonize the feeding-inhibitory effect of LPS in animal models of systemic bacterial infections.

Role of cytokines

It is well known that cytokines orchestrate non-specific and specific immune reactions. They are broadly categorized as being pro-inflammatory or anti-inflammatory, i.e. they are involved in both the pathogenesis of signs of disease, such as anorexia and fever, and the host defence against the disease (for review, see Oppenheim, Reference Oppenheim2001). Several pro-inflammatory cytokines, such as IL-1, IL-2, IL-6, IL-8, IL-18, TNFα, interferon-γ (IFN-γ) and ciliary neurotrophic factor (CNTF), have been implicated in LPS anorexia. Each of these cytokines has been shown to inhibit eating after peripheral or central administration (for example, see Plata-Salaman, Reference Plata-Salaman1995; Langhans   Hrupka, Reference Langhans and Hrupka1999; Lambert et al. Reference Lambert, Anderson, Sleeman, Wong, Tan, Hijarunguru, Corcoran, Murray, Thabet, Yancopoulos and Wiegand2001; Netea et al. Reference Netea, Joosten, Lewis, Jensen, Voshol and Kullberg2006) and some of them are known to act synergistically (Yang et al. Reference Yang, Koseki, Meguid, Gleason and Debonis1994; Sonti et al. Reference Sonti, Ilyin and Plata-Salaman1996). The synergies are presumably related to the overlapping effects of the cytokines and to the fact that they act through converging intracellular signalling pathways. Leptin, which is not considered to be a classical cytokine, also affects immune functions and is in many aspects similar to cytokines (Sanchez-Margalet et al. Reference Sanchez-Margalet, Martin-Romero, Santos-Alvarez, Goberna, Najib and Gonzalez-Yanes2003). Leptin is also implicated in the feeding-inhibitory effect of LPS (see p. 323).

While genetic ablation of a particular cytokine or its receptor often does not substantially attenuate the anorectic effect of peripheral LPS (for review, see Langhans, Reference Langhans, Stricker and Woods2004), acute pharmacological or immunological antagonism of cytokines appears to be generally more effective (Bluthe et al. Reference Bluthe, Dantzer and Kelley1992; Porter et al. Reference Porter, Arnold and Langhans1998a, Reference Porter, Hrupka, Altreuther, Arnold and Langhans2000; Swiergiel   Dunn, Reference Swiergiel and Dunn1999; Laye et al. Reference Laye, Gheusi, Cremona, Combe, Kelley, Dantzer and Parnet2000; Harden et al. Reference Harden, du Plessis, Poole and Laburn2006). These seemingly discrepant findings may be related to the redundant and overlapping actions of the cytokines, which could permit unusually extensive developmental compensation. Accordingly, simultaneous interference with several cytokines often has a stronger effect on LPS anorexia than acute blockade of only one cytokine alone; indeed, such compound treatments are at times necessary in order to observe any effect (Swiergiel   Dunn, Reference Swiergiel and Dunn1999; Bluthe et al. Reference Bluthe, Laye, Michaud, Combe, Dantzer and Parnet2000), suggesting that pro-inflammatory cytokines can replace each other to a certain extent in mediating LPS anorexia.

Some data suggest a special role for IFN-γ in LPS anorexia (Arsenijevic et al. Reference Arsenijevic, Garcia, Vesin, Vesin, Arsenijevic, Seydoux, Girardier, Ryffel, Dulloo and Richard2000). IFN-γ is mainly produced in T-cells and natural killer cells (Billiau   Vendenbroeck, Reference Billiau, Vendenbroeck, Oppenheim and Feldmann2001), neither of which possesses TLR-4 (Beutler, Reference Beutler2002). Thus, LPS indirectly stimulates IFN-γ production through macrophage-derived IL-12 and IL-18 as well as TNFα (Doherty et al. Reference Doherty, Lange, Langstein, Alexander, Buresh and Norton1992; Billiau   Vendenbroeck, Reference Billiau, Vendenbroeck, Oppenheim and Feldmann2001). The main function of IFN-γ is to activate macrophages and EC, partly in synergy with macrophage-derived cytokines (Billiau   Vendenbroeck, Reference Billiau, Vendenbroeck, Oppenheim and Feldmann2001). Thus, by enhancing pro-inflammatory cytokine production and action, IFN-γ may be essential for the full expression of LPS anorexia (Arsenijevic et al. Reference Arsenijevic, Garcia, Vesin, Vesin, Arsenijevic, Seydoux, Girardier, Ryffel, Dulloo and Richard2000). In general, although it is clear that pro-inflammatory cytokines play a prominent role in mediating LPS anorexia, the complex interactions among several cytokines rather than the action(s) of any single cytokine appear to be crucial.

Roles of leptin and ghrelin

Leptin is another possible mediator of LPS anorexia. LPS and pro-inflammatory cytokines increase the expression and production of leptin in adipose tissue (Grunfeld et al. Reference Grunfeld, Zhao, Fuller, Pollock, Moser, Friedman and Feingold1996; Faggioni et al. Reference Faggioni, Fantuzzi, Fuller, Dinarello, Feingold and Grunfeld1998; Finck et al. Reference Finck, Kelley, Dantzer and Johnson1998), and there is a correlation between these increases and the feeding-inhibitory effects of the cytokines (Grunfeld et al. Reference Grunfeld, Zhao, Fuller, Pollock, Moser, Friedman and Feingold1996). In turn, leptin increases cytokine expression (Dixit et al. Reference Dixit, Schaffer, Pyle, Collins, Sakthivel, Palaniappan, Lillard and Taub2004). Moreover, neutralization of circulating leptin with a leptin antiserum has recently been shown to reverse the feeding-inhibitory effect of LPS (Sachot et al. Reference Sachot, Poole and Luheshi2004; Harden et al. Reference Harden, du Plessis, Poole and Laburn2006). Moreover, it was found that LPS causes an up-regulation of IL-1β and IL-1 receptor antagonist mRNA in the hypothalamus, and this effect is also attenuated by leptin antiserum (Sachot et al. Reference Sachot, Poole and Luheshi2004). These results suggest that leptin is a circulating mediator of LPS anorexia, possibly through a hypothalamic IL-1β-dependent mechanism. On the other hand, it has recently been reported (Gayle et al. Reference Gayle, Desai, Casillas, Beloosesky and Ross2006) that an anorectic dose of LPS given intraperitoneally barely increases plasma leptin in male rats despite a reduction in food intake. Studies in animals with genetic defects in the leptin system have also yielded mixed results. When compared with normal control animals LPS administration has a more pronounced feeding-suppressive effect in ob/ob (leptin-deficient) mice and it causes weaker food-intake inhibition in db/db (leptin receptor-deficient) mice (Faggioni et al. Reference Faggioni, Fuller, Moser, Feingold and Grunfeld1997) than in corresponding wild-type mice. Furthermore, a single intraperitoneal LPS injection reduces food intake similarly in lean (Fa/?) and obese (fa/fa) Zucker rats (Lugarini et al. Reference Lugarini, Hrupka, Schwartz, Plata-Salaman and Langhans2005). High doses of LPS (500 μg/kg or 1·0 mg/kg) also cause a similar initial (day 1) inhibition of feeding in lean and obese Zucker rats, although the recovery of normal food intake is somewhat delayed after the highest dose (1·0 mg/kg) in obese rats. In general, the available data suggest that leptin or functional leptin receptors are not necessary for the feeding-inhibitory effect of LPS, but that leptin nonetheless contributes to LPS anorexia in several ways.

The contribution of leptin to LPS anorexia might explain two seemingly-unrelated phenomena: (1) the attenuated feeding-inhibitory effect of LPS and pro-inflammatory cytokines after food deprivation; (2) the hypersensitivity of female individuals to LPS anorexia. As food deprivation reduces plasma leptin (Boden et al. Reference Boden, Chen, Mozzoli and Ryan1996), stimulation of leptin production by LPS in fasted individuals may fail to sufficiently increase circulating leptin for a feeding-inhibitory effect. As females appear to produce more leptin than males in response to LPS (Gayle et al. Reference Gayle, Desai, Casillas, Beloosesky and Ross2006) and are more sensitive to exogenous leptin than males (Clegg et al. Reference Clegg, Riedy, Smith, Benoit and Woods2003), leptin could well contribute to the stronger feeding-inhibitory effect of LPS in females compared with males.

Intraperitoneally administered LPS has been reported to substantially decrease circulating ghrelin (Basa et al. Reference Basa, Wang, Arteaga, Heber, Livingston and Tache2003; Hataya et al. Reference Hataya, Akamizu, Hosoda, Kanamoto, Moriyama, Kangawa, Takaya and Nakao2003; Wang et al. Reference Wang, Basa, Shaikh, Luckey, Heber, St Pierre and Tache2006). Interestingly, the LPS-induced decrease in plasma ghrelin is prevented by IL-1 receptor antagonist and indomethacin (Wang et al. Reference Wang, Basa, Shaikh, Luckey, Heber, St Pierre and Tache2006), suggesting that it is mediated by IL-1β and a prostanoid-dependent mechanism. Exogenous ghrelin antagonizes the LPS-induced inhibition of food intake and gastric emptying (Basa et al. Reference Basa, Wang, Arteaga, Heber, Livingston and Tache2003; Hataya et al. Reference Hataya, Akamizu, Hosoda, Kanamoto, Moriyama, Kangawa, Takaya and Nakao2003; Wang et al. Reference Wang, Basa, Shaikh, Luckey, Heber, St Pierre and Tache2006). Although it is unclear how LPS and cytokines inhibit gastric ghrelin production, it has been shown that ghrelin potently stimulates feeding (Tschop et al. Reference Tschop, Smiley and Heiman2000) and LPS inhibits feeding by reducing meal number (Langhans et al. Reference Langhans, Harlacher and Scharrer1989), which is at least consistent with an involvement of ghrelin.

Mode of cytokine action

Vagal afferents

Although IL-1β can activate vagal afferents (Niijima, Reference Niijima1996; Kurosawa et al. Reference Kurosawa, Uvnäs-Moberg, Miyasaka and Lundeberg1997), this mechanism does not appear to be crucial for the feeding-inhibitory effects of LPS and IL-1β. For example, subdiaphragmatic vagotomy has been reported to attenuate some cytokine-induced phenomena (Dantzer et al. Reference Dantzer, Konsman, Bluthe and Kelley2000), including inhibition of instrumental responses to obtain food induced by intraperitoneal LPS or IL-1β in mice (Bret-Dibat et al. Reference Bret-Dibat, Bluthe, Kent, Kelley and Dantzer1995). However, subdiaphragmatic vagal deafferentation, alone and in combination with celiac-superior mesenteric ganglionectomy, did not alter the anorexia after intraperitoneal injection of LPS or IL-1β in rats (Schwartz et al. Reference Schwartz, Plata-Salaman and Langhans1997; Porter et al. Reference Porter, Arnold and Langhans1998b). Subdiaphragmatic vagal deafferentation is the most selective and specific method available to lesion vagal afferents. These findings therefore show that abdominal vagal and spinal visceral afferents are not necessary for the anorectic effects of these immune stimuli, at least in the rat.

Blood–brain barrier mechanisms

Pro-inflammatory cytokines produced in response to LPS may directly act on the brain to elicit anorexia because they are actively transported across the blood–brain barrier (BBB) (Banks   Kastin, Reference Banks and Kastin1996) and also enter the brain where the BBB is ‘leaky’, i.e. in the circumventricular organs. Several lines of evidence suggest, however, that non-neural cells of the BBB are the most important site of cytokine action in response to LPS (see Fig. 1). BBB EC and perivascular cells such as microglia and macrophages, presumably together with blood monocytes, have emerged as a highly-complex regulatory interface controlling brain-mediated reactions to peripheral challenges (Licinio   Wong, Reference Licinio and Wong1997; Turrin   Rivest, Reference Turrin and Rivest2004). BBB EC and perivascular cells possess cytokine receptors (VanDam et al. Reference VanDam, DeVries, Kuiper, Zijlstra, DeBoer, Tilders and Berkenbosch1996; Deckert-Schluter et al. Reference Deckert-Schluter, Bluethmann, Kaefer, Rang and Schluter1999) as well as TLR (Laflamme   Rivest, Reference Laflamme and Rivest2001). In addition, membrane-bound CD14 is present on BBB EC under basal conditions (Lacroix et al. Reference Lacroix, Feinstein and Rivest1998), and a robust increase in CD14 mRNA levels takes place in these cells in response to a single peripheral injection of LPS (Lacroix et al. Reference Lacroix, Feinstein and Rivest1998; Rivest, Reference Rivest2003). Accordingly, peripheral administration of LPS or IL-1β leads to a rapid induction of c-fos mRNA in all non-neural cells of the BBB (Herkenham et al. Reference Herkenham, Lee and Baker1998). Furthermore, LPS and pro-inflammatory cytokines cause activation of the transcription factor NF-κB in BBB EC (Bierhaus et al. Reference Bierhaus, Chen, Liliensiek and Nawroth2000) and trigger the release of neuromodulators such as prostanoids or NO (Cao et al. Reference Cao, Matsumura, Yamagata and Watanabe1996; Nadeau   Rivest, Reference Nadeau and Rivest1999; Rivest, Reference Rivest1999). Activation of BBB EC and the feeding inhibition induced by IL-1β are both mediated by NF-κB activation. In a recent study (Nadjar et al. Reference Nadjar, Bluthe, May, Dantzer and Parnet2005) intracerebroventricular injection of a specific inhibitor of NF-κB activation was found to block the feeding-inhibitory effect of intraperitoneally-administered IL-1β and dramatically reduce IL-1β-induced c-fos expression in various brain regions. These findings strongly support the hypothesis that IL-1β-induced NF-κB activation at the BBB is a crucial step in the transmission of the immune signals mediating anorexia from the periphery to the brain.

Fig. 1. Schematic diagram of the interactions between monocytes and blood–brain barrier endothelial cells (BBB EC) in the transmission of the lipopolysaccharide (LPS)-induced immune signals causing anorexia. LPS acts on monocytes and BBB EC to stimulate the release of pro-inflammatory cytokines. In response to LPS and cytokines, BBB EC release monocyte chemoattractant protein-1 (MCP-1) which recruits additional monocytes. IL-12 and IL-18 trigger the release of interferon-γ (IFN-γ) from T-cells and natural killer (NK) cells. A major role of IFN-γ is to enhance the production and action of other pro-inflammatory cytokines. The combined action of LPS and cytokines on BBB EC finally activates cyclooxygenase-2 (COX-2) thus stimulating PGE2 production. PGE2 modulates neurons involved in control of food intake and energy balance. Perivascular cells (microglia, macrophages) and receptors (CD14, toll-like receptors, cytokine receptors) have been omitted for simplicity. For further details, see p. 323–324.

BBB EC also produce cytokines (Licinio   Wong, Reference Licinio and Wong1997; Bierhaus et al. Reference Bierhaus, Chen, Liliensiek and Nawroth2000) and show signal transducer and activator of transcription-3 activation in response to LPS (Rummel et al. Reference Rummel, Voss, Matsumura, Korte, Gerstberger, Roth and Hubschle2005). Furthermore, peripheral immune stimulation by LPS, IL-1β or TNFα triggers a rapid (within 30–90 min) increase in transcription of monocyte chemoattractant protein-1 in BBB EC and all circumventricular organs (Thibeault et al. Reference Thibeault, Laflamme and Rivest2001). Only ligands that trigger NF-κB signalling have the ability to increase monocyte chemoattractant protein-1 gene expression. The substantial increase in monocyte chemoattractant protein-1 production attracts monocytes that produce pro-inflammatory cytokines. The interaction of BBB EC and monocytes in response to LPS should thus lead to a substantial increase in local cytokine production and action (Fig. 1), which might explain several failures to relate cytokines in the systemic circulation and LPS anorexia.

An interesting feature of BBB EC is their polarization, with the luminal (blood-facing) and abluminal (brain-facing) cell membranes differing in their lipid, receptor and transporter compositions. Interestingly, constitutive and LPS-induced secretion of pro-inflammatory cytokines produced by BBB EC is polarized in favour of luminal secretion of these cytokines (Verma et al. Reference Verma, Nakaoke, Dohgu and Banks2006), whereas other mediators appear to be released abluminally (Fig. 1). Thus, despite the putative role of cytokines in LPS anorexia, it appears unlikely that BBB EC-derived cytokines act as messengers for neurons, suggesting that mediators downstream of pro-inflammatory cytokines, such as prostanoids and/or NO, fulfil this function.

Mediators downstream of cytokines

LPS and cytokines synergistically increase cyclooxygenase 2 mRNA expression in BBB EC and potently stimulate prostanoid, in particular PGE2, production (DeVries et al. Reference DeVries, Hoogendoorn, Vandijk, Zijlstra, VanDam, Breimer, Vanberkel, DeBoer and Kuiper1995; Cao et al. Reference Cao, Matsumura, Yamagata and Watanabe1996; Rivest, Reference Rivest1999). Non-specific cyclooxygenase inhibitors attenuate the anorectic effects of LPS and IL-1β (Langhans et al. Reference Langhans, Harlacher and Scharrer1989, Reference Langhans, Savoldelli and Weingarten1993). Furthermore, the cyclooxygenase 2 inhibitor NS-398, but not the cyclooxygenase 1 inhibitor resveratrol, attenuated the anorectic effect of intraperitoneal LPS and blocked the concomitant LPS-induced increase in cerebrospinal PGE2 (Lugarini et al. Reference Lugarini, Hrupka, Schwartz, Plata-Salaman and Langhans2002). Interestingly, Pecchi et al. (Reference Pecchi, Dallaporta, Thirion, Salvat, Berenbaum, Jean and Troadec2006) have recently shown a robust up-regulation of microsomal PGE synthase-1 enzyme in the brain in response to intraperitoneally- and intracerebroventricularly administered anorectic doses of IL-1β. Microsomal PGE synthase-1 catalyses the last step of PGE2 biosynthesis, and its expression is stimulated by pro-inflammatory agents. In addition, IL-1β failed to decrease food intake in microsomal PGE synthase-1(-/-) mice (Pecchi et al. Reference Pecchi, Dallaporta, Thirion, Salvat, Berenbaum, Jean and Troadec2006), although these animals developed anorexia in response to an injection of PGE2. Together these results demonstrate that microsomal PGE synthase-1 is essential for IL-1β-induced anorexia. All these findings are consistent with the notion that LPS and cytokines act on BBB EC (Fig. 1) to trigger the production and release of PGE2, which acts on neurons that are involved in, or are connected to, brain sites involved in food-intake control.

Central nervous system mechanisms

Cytokines

Neurons in various brain areas increase expression of several pro-inflammatory cytokines, their accessory proteins and their receptors in response to peripheral administration of LPS (Gabellec et al. Reference Gabellec, Griffais, Fillion and Haour1995; Gayle et al. Reference Gayle, Ilyin and Plata-Salaman1997b; Turrin et al. Reference Turrin, Gayle, Ilyin, Flynn, Langhans, Schwartz and Plata-Salaman2001). While it appears unlikely that centrally produced cytokines are the exclusive mediators of peripheral LPS anorexia (for review, see Langhans, Reference Langhans, Stricker and Woods2004), they may contribute under certain circumstances. Leptin increases hypothalamic IL-1β, central injection of IL-1 receptor antagonist inhibited the hypophagic effect of central or peripheral injection of leptin and IL-1 receptor-knock-out mice did not reduce food intake in response to leptin (Luheshi et al. Reference Luheshi, Gardner, Rushforth, Loudon and Rothwell1999). These data suggest that hypothalamic IL-1β contributes to the feeding-inhibitory effect of leptin. As leptin is a possible mediator of LPS anorexia (see p. 323), central IL-1β might also be involved in peripheral LPS anorexia. More recently, Wisse et al. (Reference Wisse, Ogimoto and Schwartz2006) have shown that the melanocortin antagonist SHU9119 blunts the LPS-mediated increase in hypothalamic IL-1β, but that pharmacological or genetic disruption of IL-1 receptor signalling does not prevent the anorexia induced by the melanocortin agonist MTII. These data question the role of central IL-1β as a major mediator of LPS anorexia because SHU9119 (Huang et al. Reference Huang, Hruby and Tatro1999) and genetic lack of the melanocortin-4 receptor (Marks et al. Reference Marks, Ling and Cone2001) attenuated the feeding-suppressive effect of LPS. Other direct tests of the role of central IL-1β have also yielded inconsistent results; while intracerebroventricular administration of IL-1 receptor antagonist failed to inhibit the feeding-inhibitory effect of intraperitoneal LPS in rats (Bluthe et al. Reference Bluthe, Dantzer and Kelley1992), it did attenuate the effect of intraperitoneal LPS in mice (Laye et al. Reference Laye, Gheusi, Cremona, Combe, Kelley, Dantzer and Parnet2000). The reason for this discrepancy is unclear.

CNTF, a trophic factor for motor neurons in the ciliary ganglion and spinal cord, has been found to markedly reduce food intake and body weight (see Lambert et al. Reference Lambert, Anderson, Sleeman, Wong, Tan, Hijarunguru, Corcoran, Murray, Thabet, Yancopoulos and Wiegand2001). IL-1β is essential for CNTF production in response to brain injury or trauma (Herx et al. Reference Herx, Rivest and Yong2000), raising the possibility that CNTF may also be a downstream mediator of IL-1β effects on food intake. Some data suggest that CNTF ultimately affects energy balance by reducing the expression and action of neuropeptide Y (Xu et al. Reference Xu, Dube, Kalra, Farmerie, Kaibara, Moldawer, Martin and Kalra1998). A reduction in hypothalamic neuropeptide Y mRNA has also been reported during IL-1β-induced anorexia (Gayle et al. Reference Gayle, Ilyin and Plata-Salaman1997a), although the decrease in neuropeptide Y expression appears to be too small to account for the substantial reduction in food intake. It is possible, however, that cytokine-induced decreases in neuropeptide Y attenuate the feeding that normally occurs in response to an energy deficit (Inui, Reference Inui1999). Recently, it has been reported (Steinberg et al. Reference Steinberg, Watt, Fam, Proietto, Andrikopoulos, Allen, Febbraio and Kemp2006) that a potent CNTF analogue and leptin reduce food intake and hypothalamic AMP kinase expression similarly. Numerous reports in the last few years suggest that hypothalamic AMP kinase functions as an energy sensor in the control of energy balance (Small et al. Reference Small, Carling and Bloom2004).

Serotonin

The increase in c-fos expression (i.e. the activation) in medullary and hypothalamic paraventricular neurons that is elicited by LPS or cytokine treatment (Elmquist   Saper, Reference Elmquist and Saper1996; Ericsson et al. Reference Ericsson, Arias and Sawchenko1997; Lacroix   Rivest, Reference Lacroix and Rivest1997) appears to be mediated by PGE2 (Ericsson et al. Reference Ericsson, Arias and Sawchenko1997; Lacroix   Rivest, Reference Lacroix and Rivest1997). This finding is interesting because serotonin (5-HT) and catecholamine cell groups in the midbrain and hindbrain, but not in the paraventricular nucleus, possess PG EP3 receptors and are activated by PGE2 (Ericsson et al. Reference Ericsson, Arias and Sawchenko1997; Nakamura et al. Reference Nakamura, Li, Kaneko, Katoh and Negishi2001). Serotonergic projections from the midbrain raphe area and the hindbrain to the hypothalamus are particularly interesting candidate pathways for the anorectic effects of LPS and cytokines. First, it has recently been observed (BS Kopf, N Geary, W Langhans and L Asarian, unpublished results) that intraperitoneal LPS increases c-fos in large parts of the raphe. Second, it has also been found (see Langhans, Reference Langhans, Stricker and Woods2004) that microinjection of a cyclooxygenase 2 inhibitor into the dorsal raphe nucleus markedly reduces anorexia following intraperitoneal LPS, and that microinjection of PGE2 into the same area decreases food intake. The dorsal raphe nucleus also contains IL-1 receptors (Cunningham et al. Reference Cunningham, Wada, Carter, Tracey, Battey and Desouza1992), and central as well as peripheral administration of IL-1β and TNFα increased serotonergic activity in this area (Clement et al. Reference Clement, Buschmann, Rex, Grote, Opper, Gemsa and Wesemann1997). 5-HT potently inhibits eating, apparently mainly through the 5-HT1B and/or 5-HT2C receptors (Simansky, Reference Simansky1995; Nonogaki et al. Reference Nonogaki, Strack, Dallman and Tecott1998). Pretreatment with a highly-specific 5-HT2C receptor antagonist blocked the anorexia induced by both peripheral and central injection of LPS or IL-1β in rats (von Meyenburg et al. Reference von Meyenburg, Langhans and Hrupka2003a,b). Furthermore, administration of the 5-HT1A autoreceptor agonist 8-hydroxy-2-di-n-propylamino-tetralin directly into the dorsal raphe nucleus blocked the feeding-inhibitory effect of peripheral LPS and IL-1β (von Meyenburg et al. Reference von Meyenburg, Langhans and Hrupka2003a,b), whereas pharmacological antagonism of other 5-HT receptors (5-HT1B, 5-HT2A, 5-HT3) did not. Pharmacological 5HT2C antagonism also attenuated the feeding-inhibitory effect of intraperitoneal LPS in mice, although LPS did not reduce food intake in 5-HT2C-knock-out mice (Asarian et al. Reference Asarian, Kopf, Geary and Langhans2007). In addition, some pharmacological data in mice (Swiergiel   Dunn, Reference Swiergiel and Dunn2000) suggest that the involvement of central 5-HT neurons in LPS and cytokine-induced anorexia is situationally variable. In summary, therefore, although several findings implicate the 5-HT neurons in the median raphe nucleus and 5-HT2C receptors in the hypothalamus in LPS anorexia, it is not yet clear whether this mechanism plays a necessary role, at least in mice. Finally, emerging evidence indicates that 5-HT modulates the release of endogenous agonists and antagonists of brain melanocortin receptors, which are crucial for the central control of energy balance (Heisler et al. Reference Heisler, Cowley, Tecott, Fan, Low and Smart2002, Reference Heisler, Jobst, Sutton, Zhou, Borok and Thornton-Jones2006).

Neuropeptides

LPS increases the number of glucagon-like peptide-1 neurons in the nucleus of the solitary tract that express c-fos (Rinaman Reference Rinaman1999), and both 3rd-intracerebroventricular and 4th-intracerebroventricular administration of the glucagon-like peptide-1 receptor antagonist exendin-(9–39) attenuated the anorectic response to intraperitoneal LPS in rats (Comer   Rinaman Reference Comer and Rinaman2000; Grill et al. Reference Grill, Carmody, Sadacca, Williams and Kaplan2004). These findings have recently been extended by Grill et al. (Reference Grill, Carmody, Sadacca, Williams and Kaplan2004) to show that 3rd-intracerebroventricular administration of exendin is ineffective when the caudal flow of cerebrospinal fluid is blocked by occlusion of the cerebral aqueduct, which suggests that LPS anorexia is mediated in part by release of glucagon-like peptide-1 within the caudal brain stem.

Recent findings (Becskei et al. Reference Becskei, Hernadfalvy, Arsenijevic, Lutz and Langhans2006) suggest that peripheral LPS reduces c-fos expression in the lateral hypothalamic area and decreases the number of lateral hypothalamic area neurons expressing orexin-A protein in mice deprived of food for 12 h. As orexin-A has a potent orexigenic effect (Rodgers et al. Reference Rodgers, Ishii, Halford and Blundell2002), this finding raises the possibility that a decrease in orexin-A expression contributes to LPS anorexia. Since orexin-A is mainly implicated in arousal (Rodgers et al. Reference Rodgers, Ishii, Halford and Blundell2002), the inhibitory effect of LPS on orexin-A protein-expressing neurons might also be involved in LPS-induced lethargy and inactivity.

Peripheral injection of IL-1β increased hypothalamic corticotrophin-releasing factor mRNA (Suda et al. Reference Suda, Tozawa, Ushiyama, Sumitomo, Yamada and Demura1990), and IL-1β-induced anorexia was attenuated by 3rd-intracerebroventricular administration of a corticotrophin-releasing factor antagonist (Uehara et al. Reference Uehara, Sekiya, Takasugi, Namiki and Arimura1989), suggesting that hypothalamic corticotrophin-releasing factor is involved in IL-1β-induced anorexia. Prostanoids mediate the effect of IL-1β on hypothalamic corticotrophin-releasing factor release (Watanabe et al. Reference Watanabe, Morimoto, Sakata and Murakami1990), suggesting a link between the putative role of PGE2 (Langhans et al. Reference Langhans, Savoldelli and Weingarten1993; Lugarini et al. Reference Lugarini, Hrupka, Schwartz, Plata-Salaman and Langhans2002) and corticotrophin-releasing factor (Uehara et al. Reference Uehara, Sekiya, Takasugi, Namiki and Arimura1989) in the anorectic effects of LPS and IL-1β.

Finally, LPS stimulates the release of α-melanocyte-stimulating hormone (Catania et al. Reference Catania, Suffredini and Lipton1995), which antagonizes acute-phase reactions at various levels (cytokine production, cytokine action; Lipton   Catania, Reference Lipton and Catania1998). α-Melanocyte-stimulating hormone binds to central melanocortin receptors (MCn-R; MC3-R and MC4-R), and central administration of MC4-R agonists inhibits food intake, increases energy expenditure and reduces body weight (see Tritos   Maratos-Flier, Reference Tritos and Maratos-Flier1999). In turn, deficiency of the MC4-R is associated with increases in food intake and body weight (Fan et al. Reference Fan, Boston, Kesterson, Hruby and Cone1997). Intracerebroventricular administration of α-melanocyte-stimulating hormone enhanced, and intracerebroventricular administration of the MC3-R and MC4-R antagonist SHU9119 attenuated, intraperitoneal LPS anorexia in rats (Fan et al. Reference Fan, Boston, Kesterson, Hruby and Cone1997; Huang et al. Reference Huang, Hruby and Tatro1999). More recently, the anorexia induced by intraperitoneal LPS and cytokines has also been shown to be attenuated by the endogenous MC3-R and MC4-R antagonist Agouti-related peptide and in MC4-R-knock-out mice but not in MC3-R-knock-out mice (Marks et al. Reference Marks, Butler, Turner, Brookhart and Cone2003). These results specifically implicate the central MC4-R in LPS and cytokine-induced anorexia. Given the putative role of 5-HT in the anorectic effects of LPS and IL-1β (see p. 325), it is interesting to note that the melanocortin system is a downstream target of serotonergic neurons (Heisler et al. Reference Heisler, Cowley, Tecott, Fan, Low and Smart2002, Reference Heisler, Jobst, Sutton, Zhou, Borok and Thornton-Jones2006).

Concluding remarks

In summary, the signalling pathways of LPS anorexia ultimately converge on well-known neurotransmitter and neuropeptide systems that control food intake and energy balance. Assuming that the overlap between the mechanisms of LPS anorexia and physiological satiety generalizes to the anorexia during other illnesses, the data discussed here are consistent with the view that illness-related anorexia, like other disease mechanisms, does not represent a completely new physiological adaptation, but rather results from modulation of normal homeostatic processes that operate in healthy individuals.

Finally, it is important to understand the mechanisms of illness anorexia in order to design well-targeted therapeutic approaches for this clinically-important problem. Despite considerable progress towards an understanding of these mechanisms over the last few years, however, further studies are necessary before effective and specific therapies for the various forms of illness anorexia can be proposed.

References

Abram, M, Vu, KD, Wraber, B   Doric, M (2000) Plasma cytokine response in mice with bacterial infection. Mediators of Inflammation 9, 229234.CrossRefGoogle ScholarPubMed
Akira, S (2000) Toll-like receptors: lessons from knockout mice. Biochemical Society Transactions 28, 551556.Google Scholar
Arsenijevic, D, Garcia, I, Vesin, C, Vesin, D, Arsenijevic, Y, Seydoux, J, Girardier, L, Ryffel, B, Dulloo, A   Richard, D (2000) Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS. European Cytokine Network 11, 662668.Google ScholarPubMed
Asarian, L, Kopf, BS, Geary, N   Langhans, W (2007) Pharmacological, but not genetic disruptions in 5-HT2C receptor function attenuate LPS-anorexia in mice. Pharmacology Biochemistry and Behavior 86, 493498.Google Scholar
Banks, WA   Kastin, AJ (1996) Passage of peptides across the blood-brain barrier: Pathophysiological perspectives. Life Sciences 59, 19231943.CrossRefGoogle ScholarPubMed
Basa, NR, Wang, LX, Arteaga, JR, Heber, D, Livingston, EH   Tache, Y (2003) Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neuroscience Letters 343, 2528.Google Scholar
Becskei, C, Hernadfalvy, N, Arsenijevic, D, Lutz, TA   Langhans, W (2006) Inhibitory effects of LPS on hypothalamic nuclei involved in the control of food intake. Appetite 46, 341394.Google Scholar
Beutler, B (2000) Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Current Opinion in Microbiology 3, 2328.Google Scholar
Beutler, B (2002) TLR4 as the mammalian endotoxin sensor. Current Topics in Microbiology and Immunology 270, 109120.Google Scholar
Bierhaus, A, Chen, J, Liliensiek, B   Nawroth, PP (2000) LPS and cytokine-activated endothelium. Seminars in Thrombosis and Hemostasis 26, 571587.Google Scholar
Billiau, A   Vendenbroeck, K (2001) INF-gamma. In Cytokine Reference. vol. 1: Ligands, pp. 641688 [Oppenheim, JJ and Feldmann, M editors] San Diego, CA: Academic Press.Google Scholar
Bluthe, RM, Dantzer, R   Kelley, KW (1992) Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research 573, 318320.Google Scholar
Bluthe, RM, Laye, S, Michaud, B, Combe, C, Dantzer, R   Parnet, P (2000) Role of interleukin-1 beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. European Journal of Neuroscience 12, 44474456.Google Scholar
Boden, G, Chen, X, Mozzoli, M   Ryan, I (1996) Effect of fasting on serum leptin in normal human subjects. Journal of Clinical Endocrinology and Metabolism 81, 34193423.Google ScholarPubMed
Bret-Dibat, JL, Bluthe, RM, Kent, S, Kelley, KW   Dantzer, R (1995) Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behavior and Immunity 9, 242246.CrossRefGoogle ScholarPubMed
Cao, CY, Matsumura, K, Yamagata, K   Watanabe, Y (1996) Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: A possible site of prostaglandin synthesis responsible for fever. Brain Research 733, 263272.CrossRefGoogle ScholarPubMed
Catania, A, Suffredini, AF   Lipton, JM (1995) Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects. Neuroimmunomodulation 2, 258262.Google Scholar
Clegg, DJ, Riedy, CA, Smith, KAB, Benoit, SC   Woods, SC (2003) Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 52, 682687.CrossRefGoogle ScholarPubMed
Clement, HW, Buschmann, J, Rex, S, Grote, C, Opper, C, Gemsa, D   Wesemann, W (1997) Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat. Journal of Neural Transmission 104, 981991.CrossRefGoogle ScholarPubMed
Comer, J   Rinaman, L (2000) Role of central glucagon-like peptide-1 receptor signaling in lipopolysaccharide-induced fever and anorexia. FASEB Journal 14, A87.Google Scholar
Cunningham, ET, Wada, E, Carter, DB, Tracey, DE, Battey, JF   Desouza, EB (1992) In situ histochemical-localization of type-I interleukin-1 receptor messenger-RNA in the central-nervous-system, pituitary, and adrenal-gland of the mouse. Journal of Neuroscience 12, 11011114.Google Scholar
Dantzer, R, Konsman, JP, Bluthe, RM   Kelley, KW (2000) Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Autonomic Neuroscience Basic and Clinical 85, 6065.Google Scholar
Deckert-Schluter, M, Bluethmann, H, Kaefer, N, Rang, A   Schluter, D (1999) Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. American Journal of Pathology 154, 15491561.Google Scholar
DeVries, HE, Hoogendoorn, KH, Vandijk, J, Zijlstra, FJ, VanDam, AM, Breimer, DD, Vanberkel, TJC, DeBoer, AG   Kuiper, J (1995) Eicosanoid production by rat cerebral endothelial-cells – stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. Journal of Neuroimmunology 59, 18.CrossRefGoogle Scholar
Dixit, VD, Schaffer, EM, Pyle, RS, Collins, GD, Sakthivel, SK, Palaniappan, R, Lillard, JW   Taub, DD (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. Journal of Clinical Investigation 114, 5766.CrossRefGoogle ScholarPubMed
Doherty, GM, Lange, JR, Langstein, HN, Alexander, HR, Buresh, CM   Norton, JA (1992) Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor-necrosis-factor-alpha. Journal of Immunology 149, 16661670.CrossRefGoogle ScholarPubMed
Elmquist, JK   Saper, CB (1996) Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. Journal of Comparative Neurology 374, 315331.Google Scholar
Ericsson, A, Arias, C   Sawchenko, PE (1997) Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. Journal of Neuroscience 17, 71667179.CrossRefGoogle ScholarPubMed
Exton, MS, Bull, DF   King, MG (1995) Behavioral conditioning of lipopolysaccharide-induced anorexia. Physiology and Behavior 57, 401405.Google Scholar
Faggioni, R, Fantuzzi, G, Fuller, J, Dinarello, CA, Feingold, KR   Grunfeld, C (1998) IL-1 beta mediates leptin induction during inflammation. American Journal of Physiology 274, R204R208.Google Scholar
Faggioni, R, Fuller, J, Moser, A, Feingold, KR   Grunfeld, C (1997) LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. American Journal of Physiology 42, R181R186.Google Scholar
Fan, W, Boston, BA, Kesterson, RA, Hruby, VJ   Cone, RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165168.CrossRefGoogle ScholarPubMed
Finck, BN, Kelley, KW, Dantzer, R   Johnson, RW (1998) In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology 139, 22782283.CrossRefGoogle ScholarPubMed
Gabellec, MM, Griffais, R, Fillion, G   Haour, F (1995) Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: Regulation by bacterial lipopolysaccharide (LPS) treatment. Molecular Brain Research 31, 122130.Google Scholar
Gautron, L, Mingam, R, Moranis, A, Combe, C   Laye, S (2005) Influence of feeding status on neuronal activity in the hypothalamus during lipopolysaccharide-induced anorexia in rats. Neuroscience 134, 933946.Google Scholar
Gayle, DA, Desai, M, Casillas, E, Beloosesky, R   Ross, MG (2006) Gender-specific orexigenic and anorexigenic mechanisms in rats. Life Sciences 79, 15311536.Google Scholar
Gayle, D, Ilyin, SE   Plata-Salaman, CR (1997 a) Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Research Bulletin 44, 311317.Google Scholar
Gayle, D, Ilyin, SE   Plata-Salaman, CR (1997 b) Interleukin-1 receptor type mRNA levels in brain regions from male and female rats. Brain Research Bulletin 42, 463467.CrossRefGoogle ScholarPubMed
Geary, N (2001) Sex differences in disease anorexia. Nutrition 17, 499507.CrossRefGoogle ScholarPubMed
Geary, N, Asarian, L, Sheahan, J   Langhans, W (2004) Estradiol-mediated increases in the anorexia induced by intraperitoneal injection of bacterial lipopolysaccharide in female rats. Physiology and Behavior 82, 251261.Google Scholar
Grill, HJ, Carmody, JS, Sadacca, LA, Williams, DL   Kaplan, JM (2004) Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R. American Journal of Physiology 287, R1190R1193.Google Scholar
Grunfeld, C, Zhao, C, Fuller, J, Pollock, A, Moser, A, Friedman, J   Feingold, KR (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters – A role for leptin in the anorexia of infection. Journal of Clinical Investigation 97, 21522157.Google Scholar
Harden, LM, du Plessis, I, Poole, S   Laburn, HP (2006) Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiology and Behavior 89, 146155.CrossRefGoogle ScholarPubMed
Hart, BL (1988) Biological basis of the behavior of sick animals. Neuroscience Biobehavioral Reviews 12, 123137.Google Scholar
Hataya, YJ, Akamizu, T, Hosoda, H, Kanamoto, N, Moriyama, K, Kangawa, K, Takaya, K   Nakao, K (2003) Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144, 53655371.Google Scholar
Heisler, LK, Cowley, MA, Tecott, LH, Fan, W, Low, MJ, Smart, JL et al. (2002) Activation of central melanocortin pathways by fenfluramine. Science 297, 609611.CrossRefGoogle ScholarPubMed
Heisler, LK, Jobst, EE, Sutton, GM, Zhou, LG, Borok, E, Thornton-Jones, Z et al. (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51, 239249.Google Scholar
Herkenham, M, Lee, HY   Baker, RA (1998) Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: A cascade of non-neuronal cellular activation at the blood-brain barrier. Journal of Comparative Neurology 400, 175196.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Herx, LM, Rivest, S   Yong, VW (2000) Inflammatory cytokine regulation of neurotrophism following brain trauma: A requirement for interleukin-1 beta in the production of ciliary neurotrophic factor. Journal of Neurochemistry 74, S69.Google Scholar
Huang, QH, Hruby, VJ   Tatro, JB (1999) Role of central melanocortins in endotoxin-induced anorexia. American Journal of Physiology 276, R864R871.Google Scholar
Inui, A (1999) Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders? Molecular Medicine Today 5, 7985.Google Scholar
Kurosawa, M, Uvnäs-Moberg, K, Miyasaka, K   Lundeberg, T (1997) Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. Journal of the Autonomic Nervous System 62, 7278.Google Scholar
Lacroix, S, Feinstein, D   Rivest, S (1998) The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathology 8, 625640.Google Scholar
Lacroix, S   Rivest, S (1997) Functional circuitry in the brain of immune-challenged rats: Partial involvement of prostaglandins. Journal of Comparative Neurology 387, 307324.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Laflamme, N   Rivest, S (2001) Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB Journal 15, 155163.CrossRefGoogle ScholarPubMed
Lambert, PD, Anderson, KD, Sleeman, MW, Wong, V, Tan, J, Hijarunguru, A, Corcoran, TL, Murray, JD, Thabet, KE, Yancopoulos, GD   Wiegand, SJ (2001) Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proceedings of the National Academy of Sciences USA 98, 46524657.CrossRefGoogle ScholarPubMed
Langhans, W (2000) Anorexia of infection: current prospects. Nutrition 16, 9961005.Google Scholar
Langhans, W (2004) Anorexia during disease. In Neurobiology of Food and Fluid Intake, 2nd ed., pp. 347379 [Stricker, E and Woods, SC editors] New York: Kluwer Academic/Plenum Publishers.Google Scholar
Langhans, W, Balkowski, G   Savoldelli, D (1991) Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide. American Journal of Physiology 261, R659R664.Google Scholar
Langhans, W, Harlacher, R   Scharrer, E (1989) Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiology and Behavior 46, 535539.Google Scholar
Langhans, W   Hrupka, B (1999) Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33, 415424.Google Scholar
Langhans, W, Savoldelli, D   Weingarten, S (1993) Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiology and Behavior 53, 643649.CrossRefGoogle ScholarPubMed
Laye, S, Gheusi, G, Cremona, S, Combe, C, Kelley, K, Dantzer, R   Parnet, P (2000) Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. American Journal of Physiology 279, R93R98.Google Scholar
Lennie, TA (1998) Relationship of body energy status to inflammation-induced anorexia and weight loss. Physiology and Behavior 64, 475481.Google Scholar
Licinio, J   Wong, ML (1997) Pathways and mechanisms for cytokine signaling of the central nervous system. Journal of Clinical Investigation 100, 29412947.CrossRefGoogle ScholarPubMed
Lipton, JM   Catania, A (1998) Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Annals of the New York Academy of Sciences 840, 373380.CrossRefGoogle ScholarPubMed
Lugarini, F, Hrupka, BJ, Schwartz, GJ, Plata-Salaman, CR   Langhans, W (2002) A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. American Journal of Physiology 283, R862R868.Google ScholarPubMed
Lugarini, F, Hrupka, BJ, Schwartz, GJ, Plata-Salaman, CR   Langhans, W (2005) Acute and chronic administration of immunomodulators induces anorexia in Zucker rats. Physiology and Behavior 84, 165173.Google Scholar
Luheshi, GN, Gardner, JD, Rushforth, DA, Loudon, AS   Rothwell, NJ (1999) Leptin actions on food intake and body temperature are mediated by IL-1. Proceedings of the National Academy of Sciences USA 96, 70477052.CrossRefGoogle ScholarPubMed
Marks, DL, Butler, AA, Turner, R, Brookhart, G   Cone, RD (2003) Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 144, 15131523.CrossRefGoogle ScholarPubMed
Marks, DL, Ling, N   Cone, RD (2001) Role of the central melanocortin system in cachexia. Cancer Research 61, 14321438.Google Scholar
Murray, MJ   Murray, AB (1979) Anorexia of infection as a mechanism of host defense. American Journal of Clinical Nutrition 32, 593596.CrossRefGoogle ScholarPubMed
Nadeau, S   Rivest, S (1999) Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: A view from the blood-brain barrier. Neuroscience 93, 14491464.Google Scholar
Nadjar, A, Bluthe, RM, May, MJ, Dantzer, R   Parnet, P (2005) Inactivation of the cerebral NF kappa B pathway inhibits interleukin-1 beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30, 14921499.Google Scholar
Nakamura, K, Li, YQ, Kaneko, T, Katoh, H   Negishi, M (2001) Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: A double immunofluorescence study in the rat brain. Neuroscience 103, 763775.CrossRefGoogle ScholarPubMed
Netea, MG, Joosten, LAB, Lewis, E, Jensen, DR, Voshol, PJ, Kullberg, BJ et al. (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nature Medicine 12, 650656.Google Scholar
Niijima, A (1996) The afferent discharges from sensors for interleukin-1beta in the hepatoportal system in the anesthetized rat. Journal of the Autonomic Nervous System 61, 287291.Google Scholar
Nonogaki, K, Strack, AM, Dallman, MF   Tecott, LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nature Medicine 4, 11521156.Google Scholar
Ogimoto, K, Harris, MK   Wisse, BE (2006) MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta. Endocrinology 147, 44454453.CrossRefGoogle Scholar
Oppenheim, JJ (2001) Cytokines: Past, present, and future. International Journal of Hematology 74, 38.CrossRefGoogle ScholarPubMed
Pecchi, E, Dallaporta, M, Thirion, S, Salvat, C, Berenbaum, F, Jean, A   Troadec, JD (2006) Involvement of central microsomal prostaglandin E synthase-1 in IL-1 beta-induced anorexia. Physiological Genomics 25, 485492.Google Scholar
Plata-Salaman, CR (1995) Cytokines and feeding suppression: An integrative view from neurologic to molecular levels. Nutrition 11, 674677.Google ScholarPubMed
Porter, MH, Arnold, M   Langhans, W (1998 a) TNF-alpha tolerance blocks LPS-induced hypophagia but LPS tolerance fails to prevent TNF-alpha-induced hypophagia. American Journal of Physiology 274, R741R745.Google Scholar
Porter, MH, Hrupka, BJ, Altreuther, G, Arnold, M   Langhans, W (2000) Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline. American Journal of Physiology 279, R2113R2120.Google Scholar
Porter, MH, Hrupka, BJ, Langhans, W   Schwartz, GJ (1998 b) Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1 beta, LPS, and MDP. American Journal of Physiology 275, R384R389.Google Scholar
Rietschel, ET, Schletter, J, Weidemann, B, El Samalouti, V, Mattern, T, Zahringer, U et al. (1998) Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microbial Drug Resistance 4, 3744.Google Scholar
Rinaman, L (1999) Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. American Journal of Physiology 277, R582R590.Google ScholarPubMed
Rivest, S (1999) What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies. Molecular Psychiatry 4, 501507.Google Scholar
Rivest, S (2003) Molecular insights on the cerebral innate immune system. Brain Behavior and Immunity 17, 1319.Google Scholar
Rodgers, RJ, Ishii, Y, Halford, JCG   Blundell, JE (2002) Orexins and appetite regulation. Neuropeptides 36, 303325.Google Scholar
Rummel, C, Voss, T, Matsumura, K, Korte, S, Gerstberger, R, Roth, J   Hubschle, T (2005) Nuclear STAT3 translocation in guinea pig and rat brain endothelium during systemic challenge with lipopolysaccharide and interleukin-6. Journal of Comparative Neurology 491, 114.Google Scholar
Sachot, C, Poole, S   Luheshi, GN (2004) Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. Journal of Physiology 561, 263272.Google Scholar
Sanchez-Margalet, V, Martin-Romero, C, Santos-Alvarez, J, Goberna, R, Najib, S   Gonzalez-Yanes, C (2003) Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clinical and Experimental Immunology 133, 1119.CrossRefGoogle ScholarPubMed
Schutt, C, Bernheiden, M, Grunwald, U, Stelter, F, Menzel, R, Muller, HP, Fan, X   Jack, RS (1999) Implications for a general role of LPS-binding proteins (CD14, LBP) in combating bacterial infections. Journal of Endotoxin Research 5, 7580.CrossRefGoogle Scholar
Schwartz, GJ, Plata-Salaman, CR   Langhans, W (1997) Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats. American Journal of Physiology 273, R1193R1198.Google Scholar
Simansky, KJ (1995) Serotonergic control of the organization of feeding and satiety. Behavioural Brain Research 73, 3742.Google Scholar
Small, CJ, Carling, D   Bloom, SR (2004) Cellular energy sensor balances the scales. Nature Medicine 10, 681682.Google Scholar
Sonti, G, Ilyin, SE   Plata-Salaman, CR (1996) Anorexia induced by cytokine interactions at pathophysiological concentrations. American Journal of Physiology 270, R1394R1402.Google Scholar
Steinberg, GR, Watt, MJ, Fam, BC, Proietto, J, Andrikopoulos, S, Allen, AM, Febbraio, MA   Kemp, BE (2006) Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147, 39063914.Google Scholar
Suda, T, Tozawa, F, Ushiyama, T, Sumitomo, T, Yamada, M   Demura, H (1990) Interleukin-1 stimulates corticotropin-releasing factor gene-expression in rat hypothalamus. Endocrinology 126, 12231228.Google Scholar
Swiergiel, AH   Dunn, AJ (1999) The roles of IL-1, IL-6, and TNF alpha in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behavior and Immunity 13, 252265.Google Scholar
Swiergiel, AH   Dunn, AJ (2000) Lack of evidence for a role of serotonin in interleukin-1-induced hypophagia. Pharmacology Biochemistry and Behavior 65, 531537.CrossRefGoogle ScholarPubMed
Thibeault, I, Laflamme, N   Rivest, S (2001) Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. Journal of Comparative Neurology 434, 461477.CrossRefGoogle ScholarPubMed
Tritos, NA   Maratos-Flier, E (1999) Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone. Neuropeptides 33, 339349.Google Scholar
Tschop, M, Smiley, DL   Heiman, ML (2000) Ghrelin induces adiposity in rodents. Nature 407, 908913.Google Scholar
Turrin, NP, Gayle, D, Ilyin, SE, Flynn, MC, Langhans, W, Schwartz, GJ   Plata-Salaman, CR (2001) Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Research Bulletin 54, 443453.Google Scholar
Turrin, NP   Rivest, S (2004) Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Experimental Biology and Medicine 229, 9961006.CrossRefGoogle ScholarPubMed
Uehara, A, Sekiya, C, Takasugi, Y, Namiki, M   Arimura, A (1989) Anorexia induced by interleukin-1 – involvement of corticotropin-releasing factor. American Journal of Physiology 257, R613R617.Google Scholar
VanDam, AM, DeVries, HE, Kuiper, J, Zijlstra, FJ, DeBoer, AG, Tilders, FJH   Berkenbosch, F (1996) Interleukin-1 receptors on rat brain endothelial cells: A role in neuroimmune interaction? FASEB Journal 10, 351356.Google Scholar
Vega, VL, de Cabo, R   De Maio, A (2004) Age and caloric restriction diets are confounding factors that modify the response to lipopolysaccharide by peritoneal macrophages in C57BL/6 mice. Shock 22, 248253.CrossRefGoogle ScholarPubMed
Verma, S, Nakaoke, R, Dohgu, S   Banks, WA (2006) Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behavior and Immunity 20, 449455.CrossRefGoogle ScholarPubMed
von Meyenburg, C, Hrupka, BH, Arsenijevic, D, Schwartz, GJ, Landmann, R   Langhans, W (2004) Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia. American Journal of Physiology 287, R298R305.Google ScholarPubMed
von Meyenburg, C, Langhans, W   Hrupka, BJ (2003 a) Evidence for a role of the 5-HT2C receptor in central lipopolysaccharide-, interleukin-1 beta-, and leptin-induced anorexia. Pharmacology Biochemistry and Behavior 74, 10251031.Google Scholar
von Meyenburg, C, Langhans, W   Hrupka, BJ (2003 b) Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor. Pharmacology Biochemistry and Behavior 74, 505512.Google Scholar
Wang, LX, Basa, NR, Shaikh, A, Luckey, A, Heber, D, St Pierre, DH   Tache, Y (2006) LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. American Journal of Physiology 291, G611G620.Google Scholar
Watanabe, T, Morimoto, A, Sakata, Y   Murakami, N (1990) ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experientia 46, 481484.Google Scholar
Weingarten, S, Senn, M   Langhans, W (1993) Does a learned taste-aversion contribute to the anorectic effect of bacterial lipopolysaccharide. Physiology and Behavior 54, 961966.Google Scholar
Wisse, BE, Ogimoto, K   Schwartz, MW (2006) Role of hypothalamic interleukin-1 beta (IL-1 beta) in regulation of energy homeostasis by melanocortins. Peptides 27, 265273.Google Scholar
Xu, B, Dube, MG, Kalra, PS, Farmerie, WG, Kaibara, A, Moldawer, LL, Martin, D   Kalra, SP (1998) Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: Comparison with leptin. Endocrinology 139, 466473.Google Scholar
Yang, ZJ, Koseki, M, Meguid, MM, Gleason, JR   Debonis, D (1994) Synergistic effect of rhTNF-alpha and rhIL-1 alpha in inducing anorexia in rats. American Journal of Physiology 267, R1056R1064.Google Scholar
Figure 0

Fig. 1. Schematic diagram of the interactions between monocytes and blood–brain barrier endothelial cells (BBB EC) in the transmission of the lipopolysaccharide (LPS)-induced immune signals causing anorexia. LPS acts on monocytes and BBB EC to stimulate the release of pro-inflammatory cytokines. In response to LPS and cytokines, BBB EC release monocyte chemoattractant protein-1 (MCP-1) which recruits additional monocytes. IL-12 and IL-18 trigger the release of interferon-γ (IFN-γ) from T-cells and natural killer (NK) cells. A major role of IFN-γ is to enhance the production and action of other pro-inflammatory cytokines. The combined action of LPS and cytokines on BBB EC finally activates cyclooxygenase-2 (COX-2) thus stimulating PGE2 production. PGE2 modulates neurons involved in control of food intake and energy balance. Perivascular cells (microglia, macrophages) and receptors (CD14, toll-like receptors, cytokine receptors) have been omitted for simplicity. For further details, see p. 323–324.